Pittsburgh-based Evoqua Water Technologies announced Thursday it opened its new manufacturing facility in Singapore.
The company said the facility furthers the company’s investment in Asia-Pacific as demand grows for innovative water treatment solutions in the region.
The new 19,000-square-foot state-of-the-art facility will serve as the global manufacturing facility for Evoqua’s Ionpure Continuous Electrodeionization (CEDI) products. Evoqua’s Ionpure brand was the first to commercialize CEDI – a chemical-free, self-regenerating technology that provides a consistent flow of high-quality deionized water – for water purification.
“The establishment of this new manufacturing facility supports Evoqua’s growth and market development plans for the Asia-Pacific market,” said Ron Keating, Evoqua’s Chief Executive Officer. “Our expanded presence allows us to meet the growing needs of the APAC market, strengthening our commitment to helping our customers across the region address their critical water treatment needs.”
Officials said the new facility supports efforts to localize production and better serve the increasing demand for ultrapure water solutions in the Asia-Pacific region. The new facility is anticipated to bring nearly 30 jobs to the region.
A ceremonial ribbon-cutting for the opening of the facility was held on June 7 and featured Keating, and Hervé Fages, Evoqua’s Exec. Vice President and Applied Product Technologies Segment President.
Headquartered in Pittsburgh, Evoqua is a leading provider of mission-critical water and wastewater treatment solutions and offers a portfolio of products, services, and expertise to support industrial, municipal and recreational customers. The company has more than 150 locations in nine countries and serves more than 38,000 customers.